AXGN · ISSUER CIK 805928
Axogen, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Axogen, Inc. insiders reported $0.00 of open-market purchases and $4.7M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 4 of 4 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$4.7MInsider selling
−$4.7MNet open-market
Sep 4, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 202616:08 | Sep 2, 2026 | AXGN | Director | S · Sell10b5-1 | $49.70 | −3,500 | 10,650 | -25% | −$174K | ||
| Aug 12, 202616:13 | Aug 10, 2026 | AXGN | EVP & General Counsel | S · Sell10b5-1 | $47.35 | −67,500 | 50,135 | -57% | −$3.2M | ||
| Aug 12, 202616:13 | Aug 10, 2026 | AXGN | EVP & General Counsel | M · Exercise10b5-1 | $8.16 | +67,500 | 117,635 | +135% | $551K | ||
| Aug 12, 202616:12 | Aug 11, 2026 | AXGN | Director | S · Sell10b5-1 | $48.42 | −13,353 | 107,976 | -11% | −$647K | ||
| Aug 12, 202616:12 | Aug 11, 2026 | AXGN | Director | M · Exercise10b5-1 | $14.85 | +13,353 | 121,329 | +12% | $198K | ||
| Aug 11, 202616:15 | Aug 7, 2026 | AXGN | Director | S · Sell10b5-1 | $45.30 | −14,150 | 0 | -100% | −$641K |